ELVN vs JPM Stock Comparison

ELVN currently leads JPM in this stock comparison, with AIQ scores of 71 vs 65. The clearest difference is balanced, while JPM has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 6 points
ELVN
Healthcare
vs
JPM
Financial Services
ELVN
Enliven Therapeutics, Inc.
Leads
Price
$48.80
Day move
+1.01%
AIQ Score
71/100
Best edge
Balanced
Sector
Healthcare
JPM
JPMorgan Chase & Co.
Price
$346
Day move
+0.98%
AIQ Score
65/100
Best edge
Risk Resilience
Sector
Financial Services

What is the main difference between ELVN and JPM?

ELVN leads the current stock comparison as Enliven Therapeutics, Inc., with the clearest separation coming from balanced and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Enliven Therapeutics, Inc. vs JPMorgan Chase & Co.

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Financial Services· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

ELVN leads

ELVN leads by 6 AIQ points, having only recently taken the lead back from JPM.

Fragile: 3 of 5 evidence groups support ELVN, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Reversed
ELVN

Enliven Therapeutics, Inc.

Leads
AIQ Score
71/100
AIQ Edge Score
10/10
JPM

JPMorgan Chase & Co.

AIQ Score
65/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors ELVN over JPM, 71 versus 65 as of Nov 15, 2026. ELVN also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor ELVN today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. ELVN lead: Reversed — JPM led by 1 AIQ points 30 sessions ago; ELVN now leads by 6.

Compare Enliven Therapeutics, Inc. and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

ELVN
+105.5%
JPM
+167.7%

Total return comparison

Growth of $10,000, distributions reinvested

ELVN $20,547 · JPM $26,765

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare ELVN and JPM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ELVN advantage
0
JPM advantage
  • Risk Resilience56 vs 87
    JPM +31
  • Momentum66 vs 70
    JPM +4
  • Quality84 vs 86
    Even

3 of 5 evidence groups favor ELVN. Neither name separates cleanly on the covered dimensions.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ELVN+2 AIQ

Largest factor move: Momentum +5

No signal started or stopped since the prior session; its 6 active signals are unchanged.

JPM0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

ELVN's lead widened by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — ELVN and JPM both carry a full feed there.

The central trade-off

ELVN (Enliven Therapeutics, Inc.): the stronger current systematic profile.

JPM (JPMorgan Chase & Co.): the counter-case, on risk resilience, momentum.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ELVN

ELVN on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

ELVN

ELVN on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

JPM

JPM on the Momentum factor, by 4 points.

Lower downside

JPM

JPM on Risk Resilience, by 31 points.

Analyst upside

ELVN

ELVN on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureELVNJPMNote
Implied upside to target+50.6%+7.8%ELVN has more room
Target dispersion+10.9%+30.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1426Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor ELVN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreELVN71 vs 65
FundamentalsEvenEPS growth 26.5% vs -27.6%; TTM ROE -3.2% vs 4.1%
ValuationNot coveredNot covered
TechnicalsELVNPrice vs 50-day 5.1% vs 1.7%; vs 200-day 11.3% vs 6.6%
Risk ResilienceJPMRisk Resilience 56 vs 87
Analyst expectationsELVNTarget upside 50.6% vs 7.8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ELVN and JPM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 6 points.
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ELVN.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

ELVN lead: Reversed — JPM led by 1 AIQ points 30 sessions ago; ELVN now leads by 6.

May 27ELVN leads above the line · JPM leads belowNov 13
Today
ELVN +6
71 vs 65
7 sessions ago
ELVN +5
69 vs 64
30 sessions ago
JPM +1
62 vs 63
90 sessions ago
ELVN +19
83 vs 64

The lead changed hands once in this window, most recently on Oct 15 when JPM moved ahead of ELVN.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ELVNConflicted

4 bullish / 1 bearish / 1 neutral, conflicted

Only ELVN

  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.63%)
JPMConflicted

6 bullish / 1 bearish / 1 neutral, conflicted

Only JPM

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

Both carry 5 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, Low Volume Rally Warning, TRIX Bullish Signal, Uptrend Structure Active.

ELVN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ELVNConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +1.01%, AIQ +2 points).

JPMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
  2. 2ELVN's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
  3. 3A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricELVNJPM
Revenue growth (YoY)0%-7.6%
EPS growth (YoY)26.5%-27.6%
Gross margin0%63.2%
Operating margin0%28.2%
Return on equity (TTM)-3.2%4.1%
Debt to equity03.32

Performance

ELVN leads 4 of 6 windows
MetricELVNJPM
1 week (5 sessions)-1.3%3.5%
1 month (20 sessions)30.8%1.9%
3 months (63 sessions)-18%-4.1%
6 months (126 sessions)18%16.2%
Year to date216.9%7.4%
1 year (252 sessions)140.4%8%

Technicals

ELVN has the stronger structure
MetricELVNJPM
RSI (14)57.356.1
ADX (14)27.818
Price vs 50-day5.1%1.7%
Price vs 200-day11.3%6.6%
Volatility (1M, annualized)60.3%27.4%

Risk

JPM is the more resilient
MetricELVNJPM
Beta1.10.78
Sharpe ratio1.430.44
Sortino ratio3.070.61
Max drawdown-39%-15.5%
Current drawdown-20.2%-5.2%
Annualized volatility78.2%22.7%
Value at risk (95%)-5.2%-2.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ELVN or JPM?

On the Algovestiq AIQ Score, ELVN is the stronger of the two as of Nov 15, 2026, scoring 71 against JPM's 65. The edge comes from its factor profile. JPM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ELVN or JPM the better buy right now?

ELVN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.

Why does the AIQ Score favor ELVN over JPM?

The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Risk Resilience by 31 points; JPM leads Momentum by 4 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ELVN or JPM?

Analyst price targets imply +50.6% upside for ELVN and +7.8% for JPM, so the Street currently favors ELVN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ELVN or JPM?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ELVN or JPM?

ELVN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ELVN or JPM?

JPM on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ELVN or JPM?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 31 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ELVN more profitable than JPM?

JPM leads on the comparable margin measures — gross margin 0% vs 63.2%; operating margin 0% vs 28.2%; ttm roe -3.2% vs 4.1%.

Is ELVN's lead over JPM getting stronger or weaker?

ELVN lead: Reversed — JPM led by 1 AIQ points 30 sessions ago; ELVN now leads by 6. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-10-15, when JPM moved ahead of ELVN.

What would change the ELVN vs JPM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; ELVN's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ELVN and JPM?

ELVN: 4 bullish / 1 bearish / 1 neutral, conflicted. JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ELVN is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).

Compare ELVN and JPM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.